Ataraxia
VC Fund
Ataraxia is a VC fund focused on Food and Beverage and Alternative Protein. Ataraxia, an early stage fund manager focused on helping people live longer and live better.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ataraxia invests in
Stages Ataraxia invests in
Countries Ataraxia invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Investment Focus
Industry
- Food and Beverage 2 (67%)
- Alternative Protein 2 (67%)
- Health Care 1 (33%)
- Hospitality 1 (33%)
- Life Science 1 (33%)
Stage
- Seed 2 (67%)
- Series A 1 (33%)
Country
- Spain 1 (33%)
- France 1 (33%)
- United Kingdom 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Charles Smith
Venture Partner
|
Venture Partner | Total investments: 12 | Find email | |
Charles Smith
Venture Partner
|
Venture Partner | Total investments: 10 | Find email | |
Andrew Nealon
Partner
|
Partner | Total investments: 0 | Find email | |
Claire Cherry
Investment Partner
|
Investment Partner | Total investments: 5 | Find email | |
Holly Jacobus
Investment Partner
|
Investment Partner | Total investments: 2 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NOVAMEAT develops cutting-edge technological solutions to feed the planet’s growing population with plant-based foods in order to overcome the challenges of today’s unsustainable and inefficient animal agriculture industry and create a healthy, efficient, humane and sustainable food supply system.NOVAMEAT's proprietary technologies allowproducing plant-based meat substitutes with the same texture, appearance, taste and nutritional properties as a variety of animal meat products, including beef steaks.NOVAMEAT was recently featured on Bloomberg, Forbes, Business Insider, CBS, Techcrunch, Seeker, Mashable, Euronews, Newsweek, Mirror, El Pais, and CNN. | $6M / Seed / Feb 18, 2022 | ||
| C the Signs gives GPs the ability to simultaneously check combinations of signs, symptoms and risk factors, in an easy to use format. It can be used during the consultation, when the opportunity to influence decision-making is at its greatest. Covering the entire spectrum of Cancer and cross-referencing multiple diagnostic pathways, C the signs cansupport GPs in recommending what investigations or urgent referrals the patient may need, in under 30 seconds. | $6.8M / Series A / Feb 04, 2022 | ||
| GOURMEY is France's pioneering cultivated meat company. We create sustainable cultivated meat delights for an uncompromising and conscious generation. | $10M / Seed / Jul 14, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ataraxia invest in?
Ataraxia invests primarily in Food and Beverage, Alternative Protein and Health Care startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ataraxia?
Public channels for Ataraxia include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ataraxia?
The team at Ataraxia includes Charles Smith (Venture Partner), Charles Smith (Venture Partner) and Andrew Nealon (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
